Mitsubishi Electric Corporation, founded in 1921 and headquartered in Tokyo, Japan, is a global leader in electrical and electronic equipment. The company offers a diverse range of products and services, including air conditioning systems, automotive equipment, elevators and escalators, factory automation systems, power systems, public systems, semiconductors and devices, and space systems. Mitsubishi Electric is renowned for its innovation, quality, and sustainability initiatives, contributing to advancements in energy efficiency, smart infrastructure, and automation technologies. With a presence in over 40 countries, the company serves industries such as automotive, industrial automation, energy, transportation, and communications.
Mitsubishi Electric Corporation develops an industry-first machining architecture using physical AI to enable humanoid robots to collaborate directly with CNC machine tools.
TSN is an innovative technology that enhances Ethernet to create smart factories, synchronising devices with extreme accuracy and using IEEE 802.1 standards to prioritize messages and avoid data collisions.
David Bean, Solutions Group Manager at Mitsubishi Electric, looks at how the digital transformation of pharmaceutical operations is key to more dynamic, agile manufacturing.
Smart pharmaceutical manufacturing can do more than drive up productivity. It can transform the lives of patients by providing access to high-quality medicines while also improving the sustainability of operations and contributing to net zero policies. As a result, pharmaceutical companies can help to protect both people and the environment.